Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults
Clinical trial NCT01086449 · COMPLETED
Trial details
- NCT number
- NCT01086449
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-04
- Primary completion
- 2010-06-25
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.